40 results on '"Steens, Anneke"'
Search Results
2. Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands
3. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
4. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
5. Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019
6. COVID-19 : we need randomised trials of school closures
7. European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
8. The burden of invasive meningococcal disease in the Netherlands, 2011–2020.
9. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
10. Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands.
11. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: Implications for future impact on prevention
12. Age-Dependent Patterns of Infection and Severity Explaining the Low Impact of 2009 Influenza A (H1N1): Evidence From Serial Serologic Surveys in the Netherlands
13. Voluntary Activation and Cortical Activity During A Sustained Maximal Contraction: An fMRI Study
14. Estimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older.
15. Reduced cortical activity during maximal bilateral contractions of the index finger
16. Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021.
17. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study
18. Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts.
19. Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts.
20. Covid-19 rapportert til Folkehelseinstituttet de første seks ukene av epidemien.
21. Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020.
22. High overall confidence in childhood vaccination in Norway, slightly lower among the unemployed and those with a lower level of education.
23. Management and control of an outbreak of vaccine-preventable severe pneumococcal disease at a shipyard in Norway.
24. Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study.
25. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.
26. Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway.
27. Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study.
28. What are the most important infectious diseases among those ≥65 years: a comprehensive analysis on notifiable diseases, Norway, 1993–2011.
29. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
30. Acceptance of vaccination during pregnancy: Experience with 2009 influenza A (H1N1) in the Netherlands
31. Fatigue Perceived by Multiple Sclerosis Patients Is Associated With Muscle Fatigue.
32. High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study
33. Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
34. The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children.
35. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.
36. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004–2016.
37. Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021.
38. COVID-19 cases reported to the Norwegian Institute of Public Health in the first six weeks of the epidemic.
39. Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020.
40. In vitro and in vivo comparison of transport media for detecting nasopharyngeal carriage of Streptococcus pneumoniae.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.